| Literature DB >> 27777583 |
Dong Guo1, Jianfeng Gong1, Lei Cao1, Yao Wei1, Zhen Guo1, Weiming Zhu1.
Abstract
Aim. The study aimed to investigate the impact of laparoscopic surgery and open surgery on postoperative edema in Crohn's disease. Methods. Patients who required enterectomy were divided into open group (Group O) and laparoscopic group (Group L). Edema was measured using bioelectrical impedance analysis preoperatively (PRE) and on postoperative day 3 (POD3) and postoperative day 5 (POD5). The postoperative edema was divided into slight edema and edema by an edema index, defined as the ratio of total extracellular water to total body water. Results. Patients who underwent laparoscopic surgery had better clinical outcomes and lower levels of inflammatory and stress markers. A total of 31 patients (26.05%) developed slight edema and 53 patients (44.54%) developed edema on POD3. More patients developed postoperative edema in Group O than in Group L on POD3 (p = 0.006). The value of the edema index of Group O was higher than that of Group L on POD3 and POD5 (0.402 ± 0.010 versus 0.397 ± 0.008, p = 0.001; 0.401 ± 0.009 versus 0.395 ± 0.007, p = 0.039, resp.). Conclusions. Compared with open surgery, laparoscopic surgery can reduce postoperative edema, which may contribute to the better outcomes of laparoscopic surgery over open surgery.Entities:
Year: 2016 PMID: 27777583 PMCID: PMC5061971 DOI: 10.1155/2016/5264089
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
The demographic and baseline characteristics of patients.
| Group O ( | Group L ( |
| |
|---|---|---|---|
| Age (years) | 33.39 ± 12.21 | 31.19 ± 11.02 | 0.380b |
| Sex (female/male) | 21/40 | 19/39 | 0.847 |
| CDAI | 143.87 ± 54.76 | 146.57 ± 63.48 | 0.869b |
| Duration of disease (months) | 49.56 ± 41.22 | 48.84 ± 37.60 | 0.869b |
| History of steroid usage | 32 (52.46) | 29 (50.00) | 0.789 |
| History of infliximab | 9 (14.75) | 11 (18.97) | 0.539 |
| History of smoking | 0.923 | ||
| Never | 36 (59.02) | 34 (58.62) | |
| Former | 25 (40.98) | 24 (41.38) | |
| Montreal classification | |||
| Age of diagnosis | 0.760 | ||
| A1 ≤16 years | 5 (8.20) | 6 (10.34) | |
| A2 17–40 years | 39 (63.93) | 39 (67.24) | |
| A3 >40 years | 17 (27.87) | 13 (22.41) | |
| Disease location | 0.931 | ||
| L1 (ileum) | 18 (29.51) | 17 (29.31) | |
| L2 (colonic) | 11 (18.03) | 12 (20.69) | |
| L3 (ileocolonic) | 32 (52.46) | 29 (50.00) | |
| Disease behavior | 0.749 | ||
| B1 | 8 (13.11) | 7 (12.07) | |
| B2 (stricturing) | 36 (59.02) | 38 (65.52) | |
| B3 (fistulizing) | 17 (27.87) | 13 (22.41) | |
| Perianal disease | 18 (29.51) | 14 (24.14) | 0.509 |
| History of appendectomy | 17 (27.87 ) | 15 (25.86) | 0.805 |
| Previous abdominal operations | 0.758 | ||
| 0 | 38 (62.30) | 39 (67.24) | |
| 1 | 18 (29.51) | 16 (27.59) | |
| 2 | 5 (8.20) | 3 (5.17) | |
| ASA | 0.537 | ||
| I | 41 (67.21) | 42 (72.41) | |
| II | 20 (32.79) | 16 (27.59) | |
| Nutritional status | |||
| BMI (kg/m2) | 18.49 ± 2.53 | 18.58 ± 2.87 | 0.857b |
| Albumin (g/L) | 37.58 ± 4.07 | 37.39 ± 4.04 | 0.811b |
| Total protein (g/L) | 62.39 ± 7.84 | 63.37 ± 7.71 | 0.896b |
| Hemoglobin (g/L) | 113.79 ± 17.45 | 114.29 ± 15.95 | 0.869c |
| Soft lean mass (kg) | 40.82 ± 9.38 | 40.88 ± 8.69 | 0.994c |
| Skeletal muscle mass (kg) | 24.13 ± 5.78 | 25.14 ± 5.86 | 0.796c |
Data are n (percentages) and mean ± SD. Group O: patients who underwent open surgery; Group L: patients who underwent laparoscopic surgery; CDAI: Crohn's Disease Activity Index; ASA: American Society of Anesthesiologists; BMI: Body Mass Index.
aChi-square test, except bMann-Whitney U test, and c t-test.
Comparison of intraoperative data between groups.
| Group O ( | Group L ( |
| |
|---|---|---|---|
| Surgical indication | 0.968b | ||
| Inflammation | 3 (7.50) | 3 (7.69) | |
| Stricture | 24 (60.00) | 23 (58.97) | |
| Internal fistula/mass | 11 (27.50) | 10 (25.64) | |
| Hemorrhage | 2 (5.00) | 3 (7.69) | |
| Type of surgery | 0.629b | ||
| Small bowel resection | 11 (27.50) | 10 (25.64) | |
| Ileocolic resection | 21 (52.50) | 24 (61.54) | |
| Colonic resection | 8 (20.00) | 5 (12.82) | |
| Hand-assisted anastomosis | 11 (28.21) | ||
| Length of incision (cm) | 10.30 ± 1.79 | 5.00 ± 1.23 | <0.001 |
| Operation duration (min) | 86.85 ± 24.31 | 121.53 ± 33.62 | <0.001 |
| Blood loss (mL) | 122.25 ± 53.61 | 54.10 ± 21.97 | <0.001 |
Data are n (percentages) and mean ± SD. Group O: patients who underwent open surgery; Group L: patients who underwent laparoscopic surgery.
aMann-Whitney U test except bChi-square test.
Figure 1Postoperative fluid management. O: Group O; L: Group L. POD: postoperative day. (a) Daily volume of fluid intake after surgery including intravenous fluid intake and gastrointestinal fluid intake. (b) Daily volume of fluid output after surgery including urine output and nonurinary output. “Nonurinary output” included digestive fluid, drainage fluid, and feces. There was no difference between groups.
Comparison of clinical outcomes between groups.
| Group O ( | Group L ( |
| |
|---|---|---|---|
| Postoperative recovery | |||
| Time to flatus (hours) | 51.80 ± 14.94 | 41.40 ± 11.97 | <0.001 |
| Time to bowel movement (hours) | 75.14 ± 22.95 | 64.84 ± 19.44 | 0.004 |
| Time to tolerate EN (days) | 5.00 ± 1.43 | 4.41 ± 1.26 | 0.013 |
| Hospital stay and cost | |||
| Postoperative stay (days) | 8.64 ± 3.52 | 7.62 ± 2.86 | 0.041 |
| Total cost (USD) | 8945.82 ± 2365.90 | 9114.74 ± 2266.18 | 0.602 |
| Surgical cost (USD) | 844.00 ± 253.85 | 1132.71 ± 235.63 | <0.001 |
| Complications | 19 (31.15) | 15 (25.86) | 0.524b |
| Infection of incision | 8 (13.11) | 4 (6.90) | |
| Dehiscence of incision | 2 (3.28) | 1 (1.72) | |
| Anastomotic leakage | 2 (3.28) | 1 (1.72) | |
| Abscess/mass | 4 (6.56) | 5 (8.62) | |
| Othersc | 3 (4.92) | 4 (6.90) |
Data are n (percentages) and mean ± SD. Group O: patients who underwent open surgery; Group L: patients who underwent laparoscopic surgery. EN: enteral nutrition.
aMann-Whitney U test except bChi-square test. cOthers include urinary tract infection, throat infection, and catheter-related infection.
Figure 2Evolution of inflammatory and stress markers levels. The p values were calculated between Group O and Group L using t-test or Mann-Whitney U test. Asterisks ∗ and ∗∗ indicate statistical significance, and the p values are shown. PRE: preoperatively; POD: postoperative day.
Comparison of evolution of edema grades between groups.
| Group O ( | Group L ( |
| |
|---|---|---|---|
| PRE | 0.428 | ||
| Normal | 45 (73.77) | 43 (74.14) | |
| Slight edema | 13 (21.31) | 9 (15.52) | |
| Edema | 3 (4.92) | 6 (10.34) | |
| POD3 | 0.006 | ||
| Normal | 10 (16.39) | 25 (43.10) | |
| Slight edema | 19 (31.15) | 12 (20.69) | |
| Edema | 32 (52.46) | 21 (36.21) | |
| POD5 | 0.145 | ||
| Normal | 20 (32.79) | 26 (44.83) | |
| Slight edema | 20 (32.79) | 21 (36.21) | |
| Edema | 21 (34.43) | 11 (18.97) |
Data are n (percentages). Group O: patients who underwent open surgery; Group L: patients who underwent laparoscopic surgery; PRE: preoperatively. POD3: postoperative day 3. POD5: postoperative day 5. p values by Chi-square test.
The evolution of edema index and segmental edema index between groups.
| Group O ( | Group L ( |
| |
|---|---|---|---|
| Whole body edema | |||
| PRE | 0.388 ± 0.015 | 0.389 ± 0.008 | 0.723 |
| POD3 | 0.402 ± 0.010 | 0.397 ± 0.008 | 0.001b |
| POD5 | 0.397 ± 0.007 | 0.394 ± 0.007 | 0.039 |
| Δ3 | 0.015 ± 0.015 | 0.007 ± 0.009 | 0.002 |
| Δ5 | 0.009 ± 0.016 | 0.005 ± 0.012 | 0.383 |
| Segmental edema | |||
| Right arm | |||
| PRE | 0.374 ± 0.017 | 0.375 ± 0.011 | 0.377 |
| POD3 | 0.384 ± 0.009 | 0.379 ± 0.012 | 0.013b |
| POD5 | 0.376 ± 0.006 | 0.376 ± 0.007 | 0.994b |
| Δs3 | 0.010 ± 0.018 | 0.004 ± 0.015 | 0.238 |
| Δs5 | 0.004 ± 0.019 | 0.003 ± 0.011 | 0.491 |
| Left arm | |||
| PRE | 0.374 ± 0.009 | 0.376 ± 0.010 | 0.479 |
| POD3 | 0.384 ± 0.009 | 0.381 ± 0.012 | 0.226b |
| POD5 | 0.376 ± 0.009 | 0.378 ± 0.008 | 0.581 |
| Δs3 | 0.009 ± 0.012 | 0.006 ± 0.012 | 0.114b |
| Δs5 | 0.004 ± 0.012 | 0.004 ± 0.011 | 0.988b |
| Trunk | |||
| PRE | 0.388 ± 0.012 | 0.391 ± 0.010 | 0.181b |
| POD3 | 0.402 ± 0.013 | 0.398 ± 0.012 | 0.107 |
| POD5 | 0.396 ± 0.008 | 0.393 ± 0.009 | 0.284 |
| Δs3 | 0.014 ± 0.015 | 0.007 ± 0.013 | 0.020 |
| Δs5 | 0.006 ± 0.010 | 0.005 ± 0.011 | 0.492b |
| Right leg | |||
| PRE | 0.388 ± 0.012 | 0.391 ± 0.010 | 0.181b |
| POD3 | 0.402 ± 0.013 | 0.398 ± 0.012 | 0.107 |
| POD5 | 0.396 ± 0.008 | 0.393 ± 0.009 | 0.284 |
| Δs3 | 0.014 ± 0.015 | 0.007 ± 0.013 | 0.020 |
| Δs5 | 0.006 ± 0.010 | 0.005 ± 0.011 | 0.492b |
| Left leg | |||
| PRE | 0.391 ± 0.015 | 0.394 ± 0.010 | 0.275 |
| POD3 | 0.404 ± 0.013 | 0.402 ± 0.008 | 0.269b |
| POD5 | 0.399 ± 0.008 | 0.396 ± 0.014 | 0.316 |
| Δs3 | 0.013 ± 0.018 | 0.008 ± 0.012 | 0.045 |
| Δs5 | 0.006 ± 0.011 | 0.004 ± 0.018 | 0.971 |
Data are mean ± SD. Group O: patients who underwent open surgery; Group L: patients who underwent laparoscopic surgery. PRE: preoperatively. POD3: postoperative day 3. POD5: postoperative day 5. Δ: difference values of edema index; Δs: difference values of segmental edema index; Δ3: POD3-PRE. Δ5: POD5-PRE.
aMann-Whitney U test except b t-test.